Cataract Surgery

Shervin Korangy, CEO of BVI, shares about the company's new technology, Beyeonics One, on display during ASCRS 2022.

This advancement reinforces Alcon’s commitment to surgeon training and education, as part of the Alcon Experience Academy. The new device will be introduced at the upcoming ASCRS meeting and surgeons will be able to experience the new technology firsthand.

Beginning in the 1970s, James J. Salz, MD, was part of a group of ophthalmologists who first inserted intraocular lens implants during cataract surgery.

Novel trial design will compare safety and effectiveness outcomes for the OMNI Surgical System and the iStent inject in lowering IOP as a standalone treatment option without concomitant cataract surgery.

Physicians offer pearls to improve visualization in eyes using retroillumination techniques

“Real talk” on new devices gives surgeons, patients decision-making insights

Ophthalmologist outlines his journey with the procedure as a late adopter.

Sustained-release option is deposited directly into the lenticular capsule.

According to investigators, the risk of death from strokes, heart attacks and other vascular causes is increased by more than a third.

Three cases demonstrate value of new tools, technology for surgeons.

Techniques, technologies minimize complications and guide counseling, care.

Factors that lead to complications must be managed for best outcomes.

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Early experience with next-generation lens engenders positive perception.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Advances help gain clearer image, enhancing decision-making process.

Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

Substantial weight loss can help patients’ eye health, study results show.

Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.

Physician offers practical advice for the use of systems.

Administration has minimal impact on patients’ perception of pain.

ASCRS has issued a statement calling on Aetna to drop a new prior authorization policy it implemented last week that delays cataract surgeries.

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.

Technology enables physicians to provide and receive important information more quickly.